Rhumbline Advisers Anavex Life Sciences Corp. Transaction History
Rhumbline Advisers
- $104 Billion
- Q1 2025
A detailed history of Rhumbline Advisers transactions in Anavex Life Sciences Corp. stock. As of the latest transaction made, Rhumbline Advisers holds 120,993 shares of AVXL stock, worth $1.12 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
120,993
Previous 120,993
-0.0%
Holding current value
$1.12 Million
Previous $1.06 Million
1.61%
% of portfolio
0.0%
Previous 0.0%
Shares
28 transactions
Others Institutions Holding AVXL
# of Institutions
203Shares Held
31MCall Options Held
1.3MPut Options Held
662K-
Black Rock Inc. New York, NY6.39MShares$58.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.9MShares$45.2 Million0.0% of portfolio
-
State Street Corp Boston, MA3.21MShares$29.6 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.96MShares$18.1 Million0.0% of portfolio
-
Nwam LLC Mercer Island, WA1MShares$9.22 Million0.77% of portfolio
About ANAVEX LIFE SCIENCES CORP.
- Ticker AVXL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,942,800
- Market Cap $719M
- Description
- Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...